以色列CHEK2*1100delC与男性乳腺癌风险 - Suppr

Suppr

超能文献

CHEK2*1100delC and male breast cancer risk in Israel.

作者信息

Ohayon Tal, Gal Inbar, Baruch Ruth Gershoni, Szabo Csilla, Friedman Eitan

出版信息

Int J Cancer. 2004 Jan 20;108(3):479-80. doi: 10.1002/ijc.11603.

DOI:10.1002/ijc.11603

PMID:14648719

Abstract

摘要

相似文献

CHEK2*1100delC and male breast cancer risk in Israel.

Int J Cancer. 2004 Jan 20;108(3):479-80. doi: 10.1002/ijc.11603.

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.

Int J Cancer. 2004 Jan 20;108(3):477-8. doi: 10.1002/ijc.11385.

CHEK2 1100delC is not a risk factor for male breast cancer population.

Int J Cancer. 2004 Jan 20;108(3):475-6. doi: 10.1002/ijc.11384.

BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.

Breast Cancer Res Treat. 2008 Jul;110(1):161-7. doi: 10.1007/s10549-007-9689-2. Epub 2007 Jul 28.

CHEK2 1100delC and male breast cancer in the Netherlands.

Breast Cancer Res Treat. 2009 Jul;116(2):397-400. doi: 10.1007/s10549-008-0162-7. Epub 2008 Aug 31.

CHEK2:1100delC and female breast cancer in the United States.

Int J Cancer. 2004 Nov 10;112(3):541-3. doi: 10.1002/ijc.20439.

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Cancer Res. 2003 Dec 1;63(23):8153-7.

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Nat Genet. 2002 May;31(1):55-9. doi: 10.1038/ng879. Epub 2002 Apr 22.

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.

Breast Cancer Res Treat. 2017 Feb;161(3):575-586. doi: 10.1007/s10549-016-4085-4. Epub 2016 Dec 22.

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

BMC Cancer. 2017 Sep 5;17(1):620. doi: 10.1186/s12885-017-3631-8.

引用本文的文献

Gender-Specific Genetic Predisposition to Breast Cancer: Genes and Beyond.

Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579.

Genetic predisposition to male breast cancer in Poland.

BMC Cancer. 2021 Aug 30;21(1):975. doi: 10.1186/s12885-021-08718-3.

Genetic Landscape of Male Breast Cancer.

Cancers (Basel). 2021 Jul 15;13(14):3535. doi: 10.3390/cancers13143535.

Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.

Mol Diagn Ther. 2018 Aug;22(4):397-407. doi: 10.1007/s40291-018-0344-x.

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

BMC Cancer. 2017 Sep 5;17(1):620. doi: 10.1186/s12885-017-3631-8.

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.

Breast Cancer Res Treat. 2017 Feb;161(3):575-586. doi: 10.1007/s10549-016-4085-4. Epub 2016 Dec 22.

BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review.

Fam Cancer. 2015 Dec;14(4):515-9. doi: 10.1007/s10689-015-9819-7.

Inherited and acquired alterations in development of breast cancer.

Appl Clin Genet. 2011 Nov 14;4:145-58. doi: 10.2147/TACG.S13226. Print 2011.

Strictly defined familial male breast cancer.

Fam Cancer. 2011 Mar;10(1):73-7. doi: 10.1007/s10689-010-9400-3.

Male Breast Cancer.

Breast Care (Basel). 2008;3(3):183-189. doi: 10.1159/000136825. Epub 2008 Jun 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验